Downregulation of IL‐22 can be considered as a risk factor for onset of type 2 diabetes-Reference-Cited by-同舟云学术

Downregulation of IL‐22 can be considered as a risk factor for onset of type 2 diabetes

Published:2018-06-28 Issue:11 Volume:119 Page:9254-9260
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Asadikaram Gholamreza¹²,Akbari Hamed²³,Safi Zohreh⁴,Shadkam Mitra⁴,Khaksari Mohammad⁴⁵,Shahrokhi Nader⁴⁵,Najafipour Hamid⁴⁵,Sanjari Mojgan¹,Arababadi Mohammad Kazemi⁶⁷^ORCID

Affiliation:

1. Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences Kerman University of Medical Sciences Kerman Iran

2. Department of Biochemistry, Afzalipur Faculty of Medicine Kerman University of Medical Sciences Kerman Iran

3. Neuroscience Research Center, Institute of Neuropharmacology Kerman University of Medical Sciences Kerman Iran

4. Physiology Research Center, Institute of Basic and Clinical Physiology Sciences Kerman University of Medical Sciences Kerman Iran

5. Department of Physiology, Afzalipur Faculty of Medicine Kerman University of Medical Sciences Kerman Iran

6. Immunology of Infectious Diseases Research Center Rafsanjan University of Medical Sciences Rafsanjan Iran

7. Department of Immunology, Faculty of Medicine Rafsanjan University of Medical Sciences Rafsanjan Iran

Funder

Kerman University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27194

Reference27 articles.

1. Type 2 diabetes as an inflammatory disease

2. Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity

3. Proinflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress, and dynamics

4. The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications

5. Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota-mediated IL-22 alleviates metabolic inflammation;Life Sciences;2023-12

2. Down-regulating Interleukin-22/Interleukin-22 binding protein axis promotes inflammation and aggravates diet-induced metabolic disorders;Molecular and Cellular Endocrinology;2022-11

3. Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy;Journal of Diabetes Research;2022-06-09

4. The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials;European Journal of Pharmacology;2021-02

5. IL-22: A potential mediator of associations between urinary polycyclic aromatic hydrocarbon metabolites with fasting plasma glucose and type 2 diabetes;Journal of Hazardous Materials;2021-01